Genetic predispositions affecting GLP-1 pathway sensitivity include variants in GLP1R, GIPR, and FTO genes, which may influence receptor density, glucose homeostasis responsiveness, and weight regulation set-point
It also plays a role in many other functions, including metabolism, immune response, and blood sugar regulation
Digoxin levels should be checked, and the dosage should be adjusted as needed
In Vitro As a glucagon-like peptide-1 receptor (GLP-1R) agonist, PF-06954522 is applicable to research related to type 2 diabetes [1]
It will not count towards a pharmacy deductible
Sensitivity analyses limited to patients ages 60 years and comparisons with individual GLP-1 RAs (semaglutide and dulaglutide) yielded consistent trends